dihydroergocryptine has been researched along with pergolide in 1 studies
| Studies (dihydroergocryptine) | Trials (dihydroergocryptine) | Recent Studies (post-2010) (dihydroergocryptine) | Studies (pergolide) | Trials (pergolide) | Recent Studies (post-2010) (pergolide) |
|---|---|---|---|---|---|
| 21 | 8 | 2 | 845 | 123 | 87 |
| Protein | Taxonomy | dihydroergocryptine (IC50) | pergolide (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.379 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.385 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.264 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.2 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.111 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.385 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.064 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 1.41 | |
| D | Rattus norvegicus (Norway rat) | 0.0031 | |
| D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0031 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.2 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.041 | |
| D(2) dopamine receptor | Bos taurus (cattle) | 0.0603 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 0.679 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.041 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.041 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.513 | |
| D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0031 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.014 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.379 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.2 | |
| 5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 0.385 | |
| D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0031 | |
| 5-hydroxytryptamine receptor 1F | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 6 | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 7 | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 5A | Rattus norvegicus (Norway rat) | 0.385 | |
| 5-hydroxytryptamine receptor 5B | Rattus norvegicus (Norway rat) | 0.385 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0054 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.385 | |
| Alpha-synuclein | Homo sapiens (human) | 7.9 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.076 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.039 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0031 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.1202 | |
| 5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 0.385 | |
| D | Bos taurus (cattle) | 0.0603 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.385 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.385 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
1 review(s) available for dihydroergocryptine and pergolide
| Article | Year |
|---|---|
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |